Hôpital d'Instruction des Armées Sainte-Anne
Toulon, 83800, France
Location status: Recruiting
NCT Number: NCT04791488
The impact of oxygen therapy in many pathologies has been subject of recent work, arguing both favourable and harmful effects. Consequently, one can wonder about the influence of hyperoxic gas mixture during diving on the genesis of decompression sickness, but also about the systematic application of normobaric and hyperbaric oxygen in case of proven decompression sickness.
In mammals, normoxic concentrations have been redefined at 20-100 mbars at the extracellular level and below 10 mbars in the mitochondria.
Under hyperbaric conditions, most of the oxygen being dissolved in blood plasma, a state of hyperoxia is established which escapes the usual delivery and regulation system represented by red blood cells.
The results of our team's previous work suggest a specific effect of diving on the levels of circulating mitochondrial DNA (mtDNA), suggesting cellular destruction linked to hyperoxia/hyperbaria. In fact, our studies, carried out on both animals and human divers, have shown that diving accident leads to an increase in mtDNA levels and an immune reaction through the mobilisation of leukocytes.
The main objective of this study is to compare the influence of oxygen partial pressure levels on the evolution of clinical and biological variables during hyperbaric oxygen therapy sessions in healthy versus injured divers.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hyperbaric oxygen therapy protocol
Hyperbaric chamber diving simulation protocol
Time frame: Until the end of the oxygen therapy treatment (up to 1 year)
Decompression sickness clinical symptoms will be assessed through a medical examination after each hyperbaric session.
Decompression sickness clinical symptoms include: paresthesia, sensory deficit, motor deficit, spinal pain, sphincter disorder and brain injury.
The evolution of symptoms will be rated as following: total regression, improvement, stabilization, fluctuation or worsening
Contact information is provided by the study sponsor or research team.
Direction Centrale du Service de Santé des Armées
Other
Acronym: OXYDIVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07702539
Barotrauma, Decompression Sickness
View Trial DetailsNCT07621354
Barotrauma, Decompression Sickness
View Trial DetailsNCT06740305
Barotrauma, Decompression Sickness
Durham, North Carolina, United States
View Trial DetailsNCT06216366
Barotrauma, Decompression Sickness
Baltimore, Maryland, United States
View Trial Details